Imidazole derivatives show anticancer potential by inducing apoptosis and cellular senescence
- 28 August 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 5 (11) , 1751-1760
Abstract
Imidazole-based compounds are attractive targets in the design of novel chemical structures for the discovery of new drugs. In the current study, we have synthesized a series of new 2,4,5-trisubstituted and 1,2,4,5-tetrasubstituted imidazoles by multicomponent reaction (MCR). Vanillin and isovanillin derivatives were reacted with benzil/pyridil and diverse amines and ammonium acetate in acetic acid at 50–110 °C for 24 h to afford respective imidazoles in 55–70% yields. The series of molecules were evaluated for anti-cancer potential against the National Cancer Institute's 60 human cancer cell line panel. Preliminary screening highlighted the anticancer potential of 2,2′-(2-(3-(cyclopentyloxy)-4-methoxyphenyl)-1-isobutyl-1H-imidazole-4,5-diyl)dipyridine (NSC 771432) against different cancer cell types. A549 cells were treated in vitro to determine the mode of action of NSC 771432 on growth of these cells. This compound inhibits anchorage independent growth and cell migration, and induces cell cycle arrest in the G2/M phase. Also, the exposure of A549 cells to NSC 771432 leads to cellular senescence.Keywords
This publication has 31 references indexed in Scilit:
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008International Journal of Cancer, 2012
- Imidazole derivatives: A comprehensive survey of their recognition propertiesOrganic & Biomolecular Chemistry, 2011
- Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38α MAP kinase inhibitors with excellent in vivo antiinflammatory propertiesBioorganic & Medicinal Chemistry Letters, 2008
- The identification of potent and selective imidazole-based inhibitors of B-Raf kinaseBioorganic & Medicinal Chemistry Letters, 2006
- Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1Cannabinoid Receptor AntagonistsJournal of Medicinal Chemistry, 2004
- Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritisBioorganic & Medicinal Chemistry Letters, 2004
- Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein KinaseJournal of Medicinal Chemistry, 1999
- 2,4,5- triarylimidazole inhibitors of IL-1 biosynthesisBioorganic & Medicinal Chemistry Letters, 1995
- Preparation and antiinflammatory activity of some nonacidic trisubstituted imidazolesJournal of Medicinal Chemistry, 1974